Kolon Life Science Inc (102940) — Capital Reinvestment Ratio
Kolon Life Science Inc (102940) has a Capital Reinvestment Ratio of 3.12x as of September 2025, meaning it reinvests 3% of its operating cash flow (₩2.58 Billion) in capital expenditures (₩8.05 Billion). See Kolon Life Science Inc net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Kolon Life Science Inc Capital Reinvestment Ratio (2011–2016)
This chart tracks Kolon Life Science Inc's Capital Reinvestment Ratio across 5 annual periods. Check Kolon Life Science Inc cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Kolon Life Science Inc (2011–2016)
Year-by-year Capital Reinvestment Ratio for Kolon Life Science Inc from 2011 to 2016. For live market cap and broader valuation context, see Kolon Life Science Inc (102940) total market value.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.57x | ₩28.11 Billion | ₩16.14 Billion | ▼ -21.5% |
| 2015 | 0.73x | ₩20.81 Billion | ₩15.22 Billion | ▼ -41.1% |
| 2014 | 1.24x | ₩12.10 Billion | ₩15.01 Billion | ▼ -52.5% |
| 2012 | 2.61x | ₩23.37 Billion | ₩61.01 Billion | ▲ +10.5% |
| 2011 | 2.36x | ₩11.65 Billion | ₩27.52 Billion | — |